New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today (June 30) in Nature Microbiology, reveals an opportunity for developing a therapy against cytomegalovirus (CMV), the leading infectious cause of birth defects in the United States.
Researchers discovered a previously unappreciated mechanism by which CMV, a herpes virus that infects the majority of the world’s adult population, enters cells that line the blood vessels and…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply